QIAGEN NV (QGEN)

34.30
0.26 0.75
NYSE : Health Technology
Prev Close 34.56
Open 34.54
Day Low/High 34.24 / 34.81
52 Wk Low/High 32.33 / 41.55
Volume 781.09K
Avg Volume 868.40K
Exchange NYSE
Shares Outstanding 226.97M
Market Cap 7.90B
EPS 0.80
P/E Ratio 42.44
Div & Yield N.A. (N.A)
Qiagen Inks Deal for Digene

Qiagen Inks Deal for Digene

The Dutch molecular diagnostic company will pay $1.6 billion for its U.S. rival.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Qiagen rises on a licensing deal with Germany's Epigenomics.

Fed Heightens Risk

Don't make long-term commitments on either side of the market ahead of the FOMC meeting.

Pomp and Promise in Biotechland

Pomp and Promise in Biotechland

A very busy JPMorgan Healthcare Conference offers up some with good news and others in denial.

Nobel Win Could Boost Biotechs

Nobel Win Could Boost Biotechs

The prize awarded to two RNAi researchers is likely good for investor confidence in the sector.

Cramer's 'Mad Money Lightning Round': United Parcel Will Deliver

Cramer's 'Mad Money Lightning Round': United Parcel Will Deliver

Cramer believes the stock is headed to $100.

Cramer's 'Mad Money' Recap: ING Dutch Buoy

Cramer's 'Mad Money' Recap: ING Dutch Buoy

ING's Internet unit is driving growth at the Dutch financial services company, and the stock's likely to head higher.

Early Stocks in Motion

Early Stocks in Motion

Midway Games posts lower-than-expected earnings, while Take-Two makes an acquisition.

TheStreet Quant Rating: B (Buy)